Bristol Myers Squibb (BMY) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to 0.21.
- Bristol Myers Squibb's Equity Ratio rose 1614.11% to 0.21 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.21, marking a year-over-year increase of 1614.11%. This contributed to the annual value of 0.21 for FY2025, which is 1614.11% up from last year.
- According to the latest figures from Q4 2025, Bristol Myers Squibb's Equity Ratio is 0.21, which was up 1614.11% from 0.19 recorded in Q3 2025.
- In the past 5 years, Bristol Myers Squibb's Equity Ratio ranged from a high of 0.48 in Q4 2023 and a low of 0.17 during Q1 2024
- For the 5-year period, Bristol Myers Squibb's Equity Ratio averaged around 0.29, with its median value being 0.32 (2022).
- Per our database at Business Quant, Bristol Myers Squibb's Equity Ratio crashed by 6313.73% in 2024 and then surged by 1614.11% in 2025.
- Quarter analysis of 5 years shows Bristol Myers Squibb's Equity Ratio stood at 0.41 in 2021, then increased by 14.95% to 0.47 in 2022, then grew by 2.91% to 0.48 in 2023, then tumbled by 63.14% to 0.18 in 2024, then grew by 16.14% to 0.21 in 2025.
- Its last three reported values are 0.21 in Q4 2025, 0.19 for Q3 2025, and 0.18 during Q2 2025.